NL8601434A - Chinolinederivaten. - Google Patents

Chinolinederivaten. Download PDF

Info

Publication number
NL8601434A
NL8601434A NL8601434A NL8601434A NL8601434A NL 8601434 A NL8601434 A NL 8601434A NL 8601434 A NL8601434 A NL 8601434A NL 8601434 A NL8601434 A NL 8601434A NL 8601434 A NL8601434 A NL 8601434A
Authority
NL
Netherlands
Prior art keywords
general formula
formula
acid addition
sheet
formula sheet
Prior art date
Application number
NL8601434A
Other languages
English (en)
Dutch (nl)
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NL8601434A publication Critical patent/NL8601434A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/46Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
NL8601434A 1985-06-04 1986-06-04 Chinolinederivaten. NL8601434A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU219385 1985-06-04
HU852193A HU195487B (en) 1985-06-04 1985-06-04 Process for producing quinoline derivatives

Publications (1)

Publication Number Publication Date
NL8601434A true NL8601434A (nl) 1987-01-02

Family

ID=10958222

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8601434A NL8601434A (nl) 1985-06-04 1986-06-04 Chinolinederivaten.

Country Status (28)

Country Link
US (1) US4652562A (sv)
JP (1) JPS6248668A (sv)
KR (1) KR930006775B1 (sv)
CN (1) CN1012957B (sv)
AT (1) AT392469B (sv)
AU (1) AU588883B2 (sv)
BE (1) BE904864A (sv)
CA (1) CA1266650A (sv)
CH (1) CH668069A5 (sv)
CS (1) CS257793B2 (sv)
DD (1) DD247448A5 (sv)
DE (1) DE3618724C2 (sv)
DK (1) DK162841C (sv)
ES (1) ES8707231A1 (sv)
FI (1) FI82451C (sv)
FR (1) FR2582835B1 (sv)
GB (1) GB2176185B (sv)
GR (1) GR861452B (sv)
HU (1) HU195487B (sv)
IL (1) IL79024A0 (sv)
IT (1) IT1204377B (sv)
NL (1) NL8601434A (sv)
NO (1) NO165635C (sv)
PH (1) PH24135A (sv)
PL (1) PL146498B1 (sv)
PT (1) PT82712B (sv)
SE (1) SE466308B (sv)
SU (1) SU1398773A3 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) * 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US8557298B2 (en) * 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20090117199A1 (en) * 1998-08-06 2009-05-07 Scott Timothy C Method of treatment of cancer
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
DE60119939T2 (de) * 2000-09-21 2006-11-30 Smithkline Beecham P.L.C., Brentford Chinolinderivate als antibakterielle mittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU165520B (sv) * 1972-05-05 1974-09-28
IE47458B1 (en) * 1977-11-07 1984-03-21 Leo Pharm Prod Ltd Quinolylguanidine derivatives

Also Published As

Publication number Publication date
CN1012957B (zh) 1991-06-26
KR870000324A (ko) 1987-02-17
IL79024A0 (en) 1986-09-30
SE8602524L (sv) 1986-12-05
SE8602524D0 (sv) 1986-06-04
FI82451B (fi) 1990-11-30
AU588883B2 (en) 1989-09-28
FR2582835A1 (fr) 1986-12-05
BE904864A (fr) 1986-12-03
HU195487B (en) 1988-05-30
NO862230L (no) 1986-12-05
DE3618724C2 (de) 1994-06-16
CS257793B2 (en) 1988-06-15
CN86103688A (zh) 1987-02-11
ES555708A0 (es) 1987-07-16
GB2176185A (en) 1986-12-17
AT392469B (de) 1991-04-10
GR861452B (en) 1986-10-03
GB8613530D0 (en) 1986-07-09
DE3618724A1 (de) 1987-01-08
NO165635B (no) 1990-12-03
AU5834486A (en) 1986-12-11
JPH0515705B2 (sv) 1993-03-02
JPS6248668A (ja) 1987-03-03
DK262186A (da) 1986-12-05
GB2176185B (en) 1988-09-28
FI862381A (fi) 1986-12-05
ATA149286A (de) 1990-09-15
US4652562A (en) 1987-03-24
PT82712A (en) 1986-07-01
ES8707231A1 (es) 1987-07-16
PT82712B (pt) 1988-04-21
PH24135A (en) 1990-03-05
FR2582835B1 (fr) 1989-01-06
CH668069A5 (de) 1988-11-30
DK162841C (da) 1992-05-04
DK262186D0 (da) 1986-06-04
FI862381A0 (fi) 1986-06-04
KR930006775B1 (ko) 1993-07-23
NO862230D0 (no) 1986-06-04
DD247448A5 (de) 1987-07-08
CA1266650A (en) 1990-03-13
HUT41008A (en) 1987-03-30
PL146498B1 (en) 1989-02-28
NO165635C (no) 1991-03-13
IT8620667A0 (it) 1986-06-04
FI82451C (sv) 1991-03-11
SE466308B (sv) 1992-01-27
SU1398773A3 (ru) 1988-05-23
DK162841B (da) 1991-12-16
IT1204377B (it) 1989-03-01

Similar Documents

Publication Publication Date Title
RU2385867C2 (ru) Замещенные производные хинолина как ингибиторы митотического кинезина
EP1807399A2 (en) Indole and benzimidazole derivatives
AU570529B2 (en) 5-heteroarylimidazol-2-ones
JPH0649697B2 (ja) 放射線治療または化学療法に有用な化合物
NL8601434A (nl) Chinolinederivaten.
EP1892245B1 (en) Antineoplastic compounds and pharmaceutical compositions thereof
JPS6140286A (ja) 強心剤として有用な1,6−ナフチリジン−2(1h)−オン
EP0901789B1 (en) Method of treating tourette's syndrome
Glazer et al. Pyridoquinoxaline N-oxides. 1. A new class of antitrichomonal agents
US6037357A (en) N-benzoyl-α-alkylated azatyrosines as anticancer agents
EP3195867A1 (en) Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof
JP2793312B2 (ja) 放射線増感剤および選択的な細胞毒素剤としての1,2,4―ベンゾトリアジンオキシド
EP0316967B1 (en) Fluorine-containing nitroimidazole derivatives and radiosensitizer comprising the same
JP2000500747A (ja) 血液調節化合物
JPS60246377A (ja) 新規な複素環化合物を含有する組成物
Humphrey Targeting histone H3K36me3-deficient cancers
CA1301770C (en) Isothiuronium salts
IE54326B1 (en) Decarboxylase-inhibiting fluorinated alkane diamine derivatives
CN116332833A (zh) 线粒体靶向光敏剂化合物及其制备方法和应用
AU2017245930A1 (en) Process for preparing oxathiazin-like compounds
JPH07278146A (ja) ベンジルグアニン誘導体
CS227333B2 (cs) Způsob výroby solí alkalických kovů sulfonových kyselin a sulfonamidových derivátů 6,6-methylen-bis(2,2,4-trimethyl-1,2-dihydrochinolinu) a jejich dimerových a triměrových kondenzačních produktů

Legal Events

Date Code Title Description
BV The patent application has lapsed